Antara Capital’s Terns Pharmaceuticals TERN Stock Holding History

Antara Capital’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-874,600	Closed	-$2.17M	–	226
2022 Q2	$2.17M	Sell	874,600 -200,234	-19%	-$400K	0.09%	134
2022 Q1	$3.19M	Buy	1,074,834 +125,000	+13%	+$534K	0.1%	124
2021 Q4	$6.71M	Buy	949,834 +175,000	+23%	+$1.46M	0.33%	64
2021 Q3	$8.07M	Sell	774,834 -1,100	-0.1%	-$11.4K	0.62%	32
2021 Q2	$9.51M	Buy	775,934 +24,121	+3%	+$411K	0.52%	41
2021 Q1	$16.3M	Buy	+751,813	New	+$16.5M	1.37%	16

Other funds holding TERN

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Antara Capital's TERN Position: Q3 2022 in Review

Antara Capital sold out of Terns Pharmaceuticals (TERN) in Q3 2022, closing a stake of 874,600 shares — an estimated $2.17M sold.

Antara Capital first reported a position in TERN in Q1 2021 and held it in 6 quarters. The position peaked at $16.3M in Q1 2021. 45 funds tracked by Wall St. Rank hold TERN as of Q3 2022.

Antara Capital reported no remaining Terns Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Antara Capital sold 874,600 Terns Pharmaceuticals shares in Q3 2022, an estimated $2.17M.
Antara Capital first reported a position in Terns Pharmaceuticals in Q1 2021 and held it in 6 quarters.
Antara Capital's Terns Pharmaceuticals position peaked at $16.3M in Q1 2021.
45 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q3 2022.

Based on Antara Capital's 13F filing for Q3 2022, filed 14 Nov 2022.